Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06653946 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

the Predictors of Hemorrhagic Transformation Subtypes in Acute Embolic Stroke Patients

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study title expanded, about 5 wordsv2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Kafrelsheikh University
152 trials monitored
See 1 trial at risk
Stroke
3,531 trials monitored
See 153 trials at risk
The investigators evaluated the impact of AF on different subtypes of post-alteplase hemorrhagic transformation of brain infarction.
Trial Details
NCT Number NCT06653946
Lead Sponsor Kafrelsheikh University
Conditions
(from sponsor)		 Ischemic Stroke, Alteplase Adverse Reaction
Related terms Ischemic Stroke
Enrollment 716 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov